18F-氟胆碱PET/CT检出前列腺癌阴茎转移
本文报道一例临床状况良好、接受全雄激素阻断治疗的寡转移性前列腺癌患者,18F-氟胆碱(F-FCH)PET/CT显示阴茎海绵体弥漫性浓聚,提示罕见的阴茎转移。文中指出F-FCH PET/CT适用于盆腔、腹部淋巴结及骨骼转移检测,但受泌尿系放射性药物排泄和肝脏强摄取影响,对肝脏和泌尿道等器官的敏感性降低。
要点
- F-FCH PET/CT可用于前列腺癌盆腔、腹部淋巴结及骨骼转移检测。
- 泌尿系排泄与肝脏强摄取会降低F-FCH PET/CT对肝脏和泌尿道等器官的敏感性。
- 阴茎弥漫性浓聚可提示罕见的阴茎转移。
核心结论
- F-FCH PET/CT在前列腺癌患者中检出阴茎海绵体弥漫性浓聚,提示罕见的阴茎转移。
研究设计与样本
- 本文为个案报道,对象为一例临床状况良好、接受全雄激素阻断治疗的寡转移性前列腺癌患者。
主要发现
- F-FCH PET/CT显示阴茎海绵体弥漫且强烈的摄取,为罕见阴茎转移的证据。
- F-FCH PET/CT适用于盆腔和腹部淋巴结及骨骼转移的检测。
临床怎么用
- 前列腺癌患者行F-FCH PET/CT时,若见阴茎弥漫性浓聚,应考虑到阴茎转移的可能。
局限性
- 本文为单个病例报道,未提供诊断效能或随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
F-Fluorocholine (F-FCH) PET/CT is widely used to study patients affected by prostate cancer. F-FCH PET/CT is suitable for the detection of pelvic and abdominal nodal and skeletal metastases. Indeed, F-FCH PET/CT sensitivity for other organs, such as the liver and the urinary tract, is lowered by the radiopharmaceutical urinary washout and intense liver uptake. Herein, we report the case of a patient affected by oligometastatic prostate cancer in good clinical condition treated with total androgen blockade. F-FCH PET/CT showed a diffuse and intense uptake in the shaft of the penis, which was an evidence of a rare penile metastasis.
引用
- Bianchi D, Rizzo A, Bonacina M, et al. Penile Metastasis From Prostate Cancer Detected by 18F-Fluorocholine PET/CT. Clin Nucl Med. 2021. PMID: 32956108. doi:10.1097/RLU.0000000000003249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。